Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.
Saved in:
| Title: | Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study. |
|---|---|
| Authors: | Lachowiez CA; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Heiblig M; Département d'hématologie clinique, Hopital Lyon Sud, Pierre Bénite, France., Aspas Requena G; Service d'hématologie clinique et thérapie cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France., Tavernier-Tardy E; Département d'hématologie clinique, Institut de Cancérologie de Loire, Saint Priest en Jarez, France., Dai F; Hematologics, Inc., Seattle, Washington., Ashango AB; Hematologics, Inc., Seattle, Washington., Peters DT; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Fang J; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., Kaempf A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Long N; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Eide CA; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Kurtz SE; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Xie W; Department of Pathology and Laboratory Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Agarwal A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Sahasrabudhe A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., McMahon CM; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., Amaya ML; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., Meyers G; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Gandhi A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Leonard J; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Hayes-Lattin B; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Maziarz RT; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Traer E; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Cook RJ; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Swords R; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Braun TP; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Saultz JN; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Eckel AM; Hematologics, Inc., Seattle, Washington., Loken MR; Hematologics, Inc., Seattle, Washington., Zeidner JF; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Tyner JW; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado. |
| Source: | Blood cancer discovery [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 437-449. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
